mafA, a novel member of the maf proto-oncogene family, displays developmental regulation and mitogenic capacity in avian neuroretina cells.

Abstract:

:Transcription factors of the Maf proto-oncogene family have been shown to participate in the regulation of several differentiation specific genes. We previously reported that a member(s) of this family is involved in the regulation of the neuroretina specific gene, QR1, through a promoter region, designated the A box, that is closely related to the Maf recognition element (MARE). We undertook an identification of Maf family genes expressed in the quail neuroretina (QNR) and we report the isolation of mafA, a gene encoding a novel member of the large Maf proteins subgroup. Expression of this gene is developmentally regulated in the neuroretina. MafA is able to bind to MARE sequence and to heterodimerize with v-Maf, MafB, Jun and Fos, but not with the small MafF and MafK proteins. Accordingly, it is able to transactivate the QR1 promoter A box. We also show that increased expression of mafA induces sustained proliferation of postmitotic QNR cells.

journal_name

Oncogene

journal_title

Oncogene

authors

Benkhelifa S,Provot S,Lecoq O,Pouponnot C,Calothy G,Felder-Schmittbuhl MP

doi

10.1038/sj.onc.1201898

subject

Has Abstract

pub_date

1998-07-16 00:00:00

pages

247-54

issue

2

eissn

0950-9232

issn

1476-5594

journal_volume

17

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Downregulation of stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in advanced human hepatocellular carcinoma.

    abstract::SAP-1 (stomach cancer-associated protein tyrosine phosphatase-1) is a transmembrane-type protein tyrosine phosphatase that has been implicated as a negative regulator of integrin-mediated signaling. The potential role of this enzyme in hepatocarcinogenesis has now been investigated by examining its expression in 32 su...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206588

    authors: Nagano H,Noguchi T,Inagaki K,Yoon S,Matozaki T,Itoh H,Kasuga M,Hayashi Y

    更新日期:2003-07-24 00:00:00

  • Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK).

    abstract::To understand the mechanism of interferon (IFN)-mediated suppression of cell cycle progression, we have earlier shown that IFN-alpha enhances the expression of underphosphorylated retinoblastoma protein by inhibiting the cyclin-dependent kinase-2 (CDK-2) activity (Kumar and Atlas, Proc. Natl. Acad. Sci. 89, 6599-6603,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201529

    authors: Mandal M,Bandyopadhyay D,Goepfert TM,Kumar R

    更新日期:1998-01-15 00:00:00

  • Rad54 and Mus81 cooperation promotes DNA damage repair and restrains chromosome missegregation.

    abstract::Rad54 and Mus81 mammalian proteins physically interact and are important for the homologous recombination DNA repair pathway; however, their functional interactions in vivo are poorly defined. Here, we show that combinatorial loss of Rad54 and Mus81 results in hypersensitivity to DNA-damaging agents, defects on both t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.16

    authors: Ghamrasni SE,Cardoso R,Li L,Guturi KK,Bjerregaard VA,Liu Y,Venkatesan S,Hande MP,Henderson JT,Sanchez O,Hickson ID,Hakem A,Hakem R

    更新日期:2016-09-15 00:00:00

  • Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.

    abstract::A proportion of extraskeletal myxoid chondrosarcomas (EMC) have been shown to have a characteristic translocation t(9;22)(q22;q12) involving the EWS gene at 22q12 and the CHN orphan nuclear receptor gene at 9q22. This translocation appears to be largely specific for EMC, but has not been detected in all such tumours. ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203156

    authors: Attwooll C,Tariq M,Harris M,Coyne JD,Telford N,Varley JM

    更新日期:1999-12-09 00:00:00

  • RNH1 regulation of reactive oxygen species contributes to histone deacetylase inhibitor resistance in gastric cancer cells.

    abstract::Histone deacetylase inhibitors (HDACis) are a promising class of anticancer epigenetic drugs, however, molecular factors influencing the responses of individual tumors to HDACi therapies remain obscure. Here, we sought to identify genes associated with HDACi resistance in gastric cancer. Treating a panel of 17 gastric...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.104

    authors: Zhu Y,Das K,Wu J,Lee MH,Tan P

    更新日期:2014-03-20 00:00:00

  • p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.

    abstract::The Li-Fraumeni Syndrome (LFS) is a rare, dominantly inherited syndrome that features high risk of cancers in childhood and early adulthood. Affected families tend to develop bone and soft tissue sarcomas, breast cancers, brain tumors, leukemias, and adrenocortical carcinomas. In some kindreds, the genetic abnormality...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202783

    authors: Quesnel S,Verselis S,Portwine C,Garber J,White M,Feunteun J,Malkin D,Li FP

    更新日期:1999-07-08 00:00:00

  • CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration.

    abstract::CD44 is a cell surface receptor for hyaluronate, a component of the extracellular matrix (ECM). Although CD44 has been implicated in tumor invasion and metastasis, the molecular mechanisms remain to be elucidated. Here we find that CD44 expressed in cancer cells is cleaved at the membrane-proximal region of the ectodo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202447

    authors: Okamoto I,Kawano Y,Tsuiki H,Sasaki J,Nakao M,Matsumoto M,Suga M,Ando M,Nakajima M,Saya H

    更新日期:1999-02-18 00:00:00

  • Kit signaling and negative regulation of daunorubicin-induced apoptosis: role of phospholipase Cgamma.

    abstract::Previous studies have demonstrated that activation of Kit by stem cell factor (SCF), its natural ligand, or by gain-of-function point mutation in its intracellular domain, confers significant protection against apoptosis induced by growth factor deprivation or radiation. However, the effects of Kit activation on the c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204877

    authors: Plo I,Lautier D,Casteran N,Dubreuil P,Arock M,Laurent G

    更新日期:2001-10-11 00:00:00

  • Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.

    abstract::The most common genetic alteration identified in transitional cell carcinoma (TCC) of the bladder is loss of heterozygosity (LOH) on chromosome 9. However, localization of tumor suppressor genes on 9q has been hampered by the low frequency of subchromosomal deletions. We have analysed 139 primary, initial low stage TC...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202277

    authors: Simoneau M,Aboulkassim TO,LaRue H,Rousseau F,Fradet Y

    更新日期:1999-01-07 00:00:00

  • Mutant p53: an oncogenic transcription factor.

    abstract::Inactivation of tumor-suppressor genes is one of the key hallmarks of a tumor. Unlike other tumor-suppressor genes, p53 is inactivated by missense mutations in half of all human cancers. It has become increasingly clear that the resulting mutant p53 proteins do not represent only the mere loss of wild-type p53 tumor s...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210296

    authors: Strano S,Dell'Orso S,Di Agostino S,Fontemaggi G,Sacchi A,Blandino G

    更新日期:2007-04-02 00:00:00

  • Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.

    abstract::Previous studies have demonstrated a synergistic interaction between rhuMAb HER2 and the cytotoxic drug cisplatin in human breast and ovarian cancer cells. To define the nature of the interaction between rhuMAb HER2 and other classes of cytotoxic drugs, we applied multiple drug effect/combination index (CI) isobologra...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202526

    authors: Pegram M,Hsu S,Lewis G,Pietras R,Beryt M,Sliwkowski M,Coombs D,Baly D,Kabbinavar F,Slamon D

    更新日期:1999-04-01 00:00:00

  • Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis.

    abstract::In both humans with long-standing ulcerative colitis and mouse models of colitis-associated carcinogenesis (CAC), tumors develop predominantly in the distal part of the large intestine but the biological basis of this intriguing pathology remains unknown. Herein we report intrinsic differences in gene expression betwe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.307

    authors: Gkouskou KK,Ioannou M,Pavlopoulos GA,Georgila K,Siganou A,Nikolaidis G,Kanellis DC,Moore S,Papadakis KA,Kardassis D,Iliopoulos I,McDyer FA,Drakos E,Eliopoulos AG

    更新日期:2016-05-12 00:00:00

  • Detection of novel mRNA splice variants of human ING4 tumor suppressor gene.

    abstract::Inhibitor of growth (ING)4, member of a gene family encoding potential tumor suppressors, is implicated as a repressor of angiogenesis and tumor growth and suppresses loss of contact inhibition in vitro. Here, we report that ING4 undergoes alternative splicing. Expression analysis identified novel ING4 spliced variant...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210335

    authors: Raho G,Miranda C,Tamborini E,Pierotti MA,Greco A

    更新日期:2007-08-09 00:00:00

  • Stabilization of prolactin receptor in breast cancer cells.

    abstract::The role of the hormone prolactin (PRL) in the pathogenesis of breast cancer is mediated by its cognate receptor (PRLr). Ubiquitin-dependent degradation of the PRLr that negatively regulates PRL signaling is triggered by PRL-mediated phosphorylation of PRLr on Ser349 followed by the recruitment of the beta-transducin ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209214

    authors: Li Y,Clevenger CV,Minkovsky N,Kumar KG,Raghunath PN,Tomaszewski JE,Spiegelman VS,Fuchs SY

    更新日期:2006-03-23 00:00:00

  • The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding.

    abstract::The BTB/POZ family of proteins has been implicated in multiple biological processes, including tumourigenesis, DNA damage responses and cell cycle progression and development. MIZ-1 (Myc-interacting zinc-finger protein 1) is known to activate transcription of CDKN1A. We recently found that a kidney cancer-related POK ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.331

    authors: Lee KM,Choi WI,Koh DI,Kim YJ,Jeon BN,Yoon JH,Lee CE,Kim SH,Oh J,Hur MW

    更新日期:2012-03-15 00:00:00

  • The HIF and other quandaries in VHL disease.

    abstract::Mutations in VHL underlie von Hippel-Lindau (VHL) disease, a hereditary cancer syndrome with several subtypes depending on the risk of developing certain combination of classic features, such as clear cell renal cell carcinoma (ccRCC), hemangioblastoma and pheochromocytoma. Although numerous potential substrates and f...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2017.338

    authors: Tarade D,Ohh M

    更新日期:2018-01-11 00:00:00

  • Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms.

    abstract::We have evaluated the transcriptional activation of a human p21 promoter reporter construct by transfection of BRCA1 expression constructs into tumorigenic and nontumorigenic human breast cell lines. Two cell lines with wildtype p53 (MCF-7 and MCF10A) demonstrated transcriptional activation of the p21 promoter by full...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204025

    authors: Lu M,Arrick BA

    更新日期:2000-12-14 00:00:00

  • GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21.

    abstract::KLF6, a ubiquitously expressed Krüppel-like transcription factor, is frequently inactivated in human cancer and has significant roles in cellular proliferation, apoptosis, differentiation and development. A key mechanism of KLF6-mediated growth suppression is through p53-independent transactivation of p21. Several can...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.457

    authors: Lang UE,Kocabayoglu P,Cheng GZ,Ghiassi-Nejad Z,Muñoz U,Vetter D,Eckstein DA,Hannivoort RA,Walsh MJ,Friedman SL

    更新日期:2013-09-19 00:00:00

  • Structural determinants of the BRCA1 : estrogen receptor interaction.

    abstract::Previously, we showed that the BRCA1 protein interacts directly and functionally with estrogen receptor-alpha (ER-alpha), resulting in the inhibition of estradiol (E2)-stimulated ER-alpha transcriptional activity. The interaction sites were mapped to the N-terminus of BRCA1 (within amino acids (aa) 1-302) and the liga...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208190

    authors: Ma YX,Tomita Y,Fan S,Wu K,Tong Y,Zhao Z,Song LN,Goldberg ID,Rosen EM

    更新日期:2005-03-10 00:00:00

  • DNA adduct burden and tobacco carcinogenesis.

    abstract::DNA adducts associated with tobacco smoking could provide a marker of biologically effective dose of tobacco carcinogens and improve individual cancer risk prediction. A significant number of clinical and epidemiologic studies have reported associations of increased DNA adduct levels with the occurrence of the prevale...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1205799

    authors: Wiencke JK

    更新日期:2002-10-21 00:00:00

  • High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.

    abstract::Soft tissue sarcomas are a heterogeneous group of neoplasms with various histological subtypes. Up to now, no individual causal molecular markers for prognosis and therapeutic success have been identified. A tumorigenic connection between the oncogene product Mdm2 and tumor suppressor p53 is generally accepted, but th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201646

    authors: Würl P,Meye A,Schmidt H,Lautenschläger C,Kalthoff H,Rath FW,Taubert H

    更新日期:1998-03-05 00:00:00

  • Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis.

    abstract::Pin1 regulates a subset of phosphoproteins by isomerizing phospho-Ser/Thr-Pro motifs via a 'post-phosphorylation' mechanism. Here, we characterize TR3 as a novel Pin1 substrate, and the mitogenic function of TR3 depends on Pin1-induced isomerization. There are at least three phospho-Ser-Pro motifs on TR3 that bind to ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.463

    authors: Chen HZ,Li L,Wang WJ,Du XD,Wen Q,He JP,Zhao BX,Li GD,Zhou W,Xia Y,Yang QY,Hew CL,Liou YC,Wu Q

    更新日期:2012-06-07 00:00:00

  • Human c-FES is a nuclear tyrosine kinase.

    abstract::FES is a non-receptor protein tyrosine kinase expressed in hematopoietic progenitors and differentiated myeloid cells. It has recently been implicated in granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3) and erythropoietin signal transduction. To better understand the role played by FES i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yates KE,Lynch MR,Wong SG,Slamon DJ,Gasson JC

    更新日期:1995-03-16 00:00:00

  • BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.

    abstract::BRCA1, a familial breast and ovarian cancer susceptibility gene encodes nuclear phosphoproteins that function as tumor suppressors in human breast cancer cells. Previously, we have shown that overexpression of a BRCA1 splice variant BRCA1a accelerates apoptosis in human breast cancer cells. In an attempt to determine ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201252

    authors: Wang H,Shao N,Ding QM,Cui J,Reddy ES,Rao VN

    更新日期:1997-07-10 00:00:00

  • Telomerase promotes efficient cell cycle kinetics and confers growth advantage to telomerase-negative transformed human cells.

    abstract::Constitutive telomerase activity maintains telomere length and confers immortal phenotypes to human cancers. The prevalence of telomerase, rather than a homologous recombination-based mechanism, in telomere length maintenance suggests that telomerase also has auxiliary roles in tumorigenesis. Here, we investigate grow...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.292

    authors: Fleisig HB,Wong JM

    更新日期:2012-02-23 00:00:00

  • The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction.

    abstract::The cell polarity regulator, human Scribble (hScrib), is a potential tumour suppressor whose loss is a frequent event in late-stage cancer development. Little is yet known about the mode of action of hScrib, although recent reports suggest its role in the regulation of cell signalling. In this study we show that hScri...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.265

    authors: Nagasaka K,Pim D,Massimi P,Thomas M,Tomaić V,Subbaiah VK,Kranjec C,Nakagawa S,Yano T,Taketani Y,Myers M,Banks L

    更新日期:2010-09-23 00:00:00

  • Retinoid-dependent antagonism of serum response factor transactivation mediated by transcriptional coactivator proteins.

    abstract::Transcriptional coactivators SRC-1 and p300 specifically interact with liganded-nuclear receptors and also modulate other transcription factors, including serum response factor (SRF). Here, we report that retinoids repress transactivation by SRF and specific interactions exist between the DNA binding domains of SRF an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204695

    authors: Kim SW,Kim HJ,Jung DJ,Lee SK,Kim YS,Kim JH,Kim TS,Lee JW

    更新日期:2001-10-04 00:00:00

  • The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases.

    abstract::The DCC (deleted in colorectal cancer) gene was originally identified as a candidate tumour suppressor gene in colon carcinogenesis on the basis of allelic losses in chromosome 18q.21 in 70% of colon cancers. Reverse transcriptase polymerase chain reaction (RT-PCR) of DCC mRNA suggests that DCC expression may also be ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Gotley DC,Reeder JA,Fawcett J,Walsh MD,Bates P,Simmons DL,Antalis TM

    更新日期:1996-08-15 00:00:00

  • Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.

    abstract::The NAD-dependent deacetylase sirtuin 1 (SIRT1), a member of the mammalian sirtuin family, plays a pivotal role in deacetylating histone and nonhistone proteins. Recently, it has been reported that SIRT1 is upregulated in various kinds of tumors and is associated with cell growth and metastasis. However, the factors a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1298-0

    authors: Yu L,Dong L,Li H,Liu Z,Luo Z,Duan G,Dai X,Lin Z

    更新日期:2020-05-01 00:00:00

  • p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer.

    abstract::The role of p53 in genotoxic therapy-induced metabolic shift in cancers is not yet known. In this study, we investigated the role of p53 in the glycolytic shift in head and neck squamous cell carcinoma cell lines following irradiation. Isogenic p53-null radioresistant cancer cells established through cumulative irradi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0697-6

    authors: Chang HW,Kim MR,Lee HJ,Lee HM,Kim GC,Lee YS,Nam HY,Lee M,Jang HJ,Lee KE,Lee JC,Byun Y,Kim SW,Kim SY

    更新日期:2019-05-01 00:00:00